The rise of selective estrogen receptor modulators (SERMs) in breast cancer therapy: a promising horizon.
- DOI
- 10.1016/j.ctarc.2026.101252
- Published
- 2026
- Container
- Cancer treatment and research communications
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctarc.2026.101252,
title = {The rise of selective estrogen receptor modulators (SERMs) in breast cancer therapy: a promising horizon.},
author = {Al-Zoubi RM and Garada K and Zarour AA and Elaarag M and Farhan A and Al-Hurani EA and Al-Zoubi SR and Fares ZE and Al-Qudimat AR and Zoubi MSA and Bawadi H and Zakaria ZZ and Agouni A and Alrumaihi K},
year = {2026},
journal = {Cancer treatment and research communications},
doi = {10.1016/j.ctarc.2026.101252},
url = {https://doi.org/10.1016/j.ctarc.2026.101252}
}RIS
TY - JOUR TI - The rise of selective estrogen receptor modulators (SERMs) in breast cancer therapy: a promising horizon. AU - Al-Zoubi RM AU - Garada K AU - Zarour AA AU - Elaarag M AU - Farhan A AU - Al-Hurani EA AU - Al-Zoubi SR AU - Fares ZE AU - Al-Qudimat AR AU - Zoubi MSA AU - Bawadi H AU - Zakaria ZZ AU - Agouni A AU - Alrumaihi K PY - 2026 JO - Cancer treatment and research communications DO - 10.1016/j.ctarc.2026.101252 UR - https://doi.org/10.1016/j.ctarc.2026.101252 ER -
APA
RM, A., K, G., AA, Z., M, E., A, F., EA, A., SR, A., ZE, F., AR, A., MSA, Z., H, B., ZZ, Z., A, A., & K, A. (2026). The rise of selective estrogen receptor modulators (SERMs) in breast cancer therapy: a promising horizon.. Cancer treatment and research communications. https://doi.org/10.1016/j.ctarc.2026.101252
Source records
- pubmed · retrieved 2026-09-26T12:18:32.931Z